UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 132

Sortiert nach

Actinohivin, a Broadly Neutralizing Prokaryotic Lectin, Inhibits HIV-1 Infection by Specifically Targeting High-Mannose-Type Glycans on the gp120 Envelope

Antimicrobial Agents and Chemotherapy, 2010-08, Vol.54 (8), p.3287-3301

2010

Link zum Volltext

Verfügbarkeit prüfen

Pradimicin S, a Highly Soluble Nonpeptidic Small-Size Carbohydrate-Binding Antibiotic, Is an Anti-HIV Drug Lead for both Microbicidal and Systemic Use

Antimicrobial Agents and Chemotherapy, 2010-04, Vol.54 (4), p.1425-1435

2010

Link zum Volltext

Verfügbarkeit prüfen

Predictive Value of HIV-1 Genotypic Resistance Test Interpretation Algorithms

The Journal of infectious diseases, 2009-08, Vol.200 (3), p.453-463

2009

Link zum Volltext

Verfügbarkeit prüfen

The genealogical population dynamics of HIV-1 in a large transmission chain: bridging within and among host evolutionary rates

PLoS computational biology, 2014-04, Vol.10 (4), p.e1003505-e1003505

2014

Link zum Volltext

Verfügbarkeit prüfen

Human Immunodeficiency Virus Type 1 Escape from Cyclotriazadisulfonamide-Induced CD4-Targeted Entry Inhibition Is Associated with Increased Neutralizing Antibody Susceptibility

Journal of Virology, 2009-09, Vol.83 (18), p.9577-9583

2009

Link zum Volltext

Verfügbarkeit prüfen

Novel Recombinant Virus Assay for Measuring Susceptibility of Human Immunodeficiency Virus Type 1 Group M Subtypes To Clinically Approved Drugs

Journal of Clinical Microbiology, 2009-07, Vol.47 (7), p.2232-2242

2009

Link zum Volltext

Verfügbarkeit prüfen

Chronic and Early Antiretroviral Therapy Impact Human Immunodeficiency Virus (HIV) Serological Assay Sensitivity, Leading to More False-Negative Test Results in HIV Diagnosis

The Journal of infectious diseases, 2020-11, Vol.222 (10), p.1660-1669

2020

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 genetic variation and drug resistance development

Expert review of anti-infective therapy, 2013-11, Vol.11 (11), p.1159-1178

2013

Link zum Volltext

Verfügbarkeit prüfen

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database

BMC infectious diseases, 2008-02, Vol.8 (1), p.21-21, Article 21

2008

Link zum Volltext

Verfügbarkeit prüfen

Quality Control of Next-Generation Sequencing-Based HIV-1 Drug Resistance Data in Clinical Laboratory Information Systems Framework

Viruses, 2020-06, Vol.12 (6), p.645

2020

Link zum Volltext

Verfügbarkeit prüfen

Nationwide quality assurance of high-throughput diagnostic molecular testing during the SARS-CoV-2 pandemic: role of the Belgian National Reference Centre

Virology journal, 2024-02, Vol.21 (1), p.40-40

2024

Link zum Volltext

Verfügbarkeit prüfen

The hepatitis C cascade of care in the Belgian HIV population: One step closer to elimination

International journal of infectious diseases, 2021-04, Vol.105, p.217-223

2021

Link zum Volltext

Verfügbarkeit prüfen

HIV genotypic drug resistance testing: digging deep, reaching wide?

Journal of Virus Eradication, 2016-05, Vol.2, p.2-2

Van Laethem, Kristel

2016

Link zum Volltext

Verfügbarkeit prüfen

Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections

Journal of virology, 2014-11, Vol.88 (21), p.12882-12894

2014

Link zum Volltext

Verfügbarkeit prüfen

Exploring HIV-1 Transmission Dynamics by Combining Phylogenetic Analysis and Infection Timing

Viruses, 2019-11, Vol.11 (12), p.1096

2019

Link zum Volltext

Verfügbarkeit prüfen

Pradimicin A, a Carbohydrate-Binding Nonpeptidic Lead Compound for Treatment of Infections with Viruses with Highly Glycosylated Envelopes, Such as Human Immunodeficiency Virus

Journal of Virology, 2007-01, Vol.81 (1), p.362-373

2007

Link zum Volltext

Verfügbarkeit prüfen

Comparative Performances of HIV-1 RNA Load Assays at Low Viral Load Levels: Results of an International Collaboration

Journal of Clinical Microbiology, 2014-02, Vol.52 (2), p.517-523

2014

Link zum Volltext

Verfügbarkeit prüfen

Stable level of HIV transmitted drug resistance in Estonia despite significant scale-up of antiretroviral therapy

Infection, genetics and evolution, 2019-11, Vol.75, p.103901-103901, Article 103901

2019

Link zum Volltext

Verfügbarkeit prüfen

Decision tree for accurate infection timing in individuals newly diagnosed with HIV-1 infection

BMC infectious diseases, 2017-11, Vol.17 (1), p.738-738, Article 738

2017

Link zum Volltext

Verfügbarkeit prüfen

Mutational Pathways, Resistance Profile, and Side Effects of Cyanovirin Relative to Human Immunodeficiency Virus Type 1 Strains with N-Glycan Deletions in Their gp120 Envelopes

Journal of Virology, 2006-09, Vol.80 (17), p.8411-8421

2006

Link zum Volltext

Verfügbarkeit prüfen

Quantifying Next Generation Sequencing Sample Pre-Processing Bias in HIV-1 Complete Genome Sequencing

Viruses, 2016-01, Vol.8 (1), p.12-12

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 132

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(132)
Mit Volltextzugriff
(119)

Publikationsform

Artikel
(132)

Sprache

Englisch
(132)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Actinohivin, a Broadly Neutralizing Prokaryotic Lectin, Inhibits HIV-1 Infection by Specifically Targeting High-Mannose-Type Glycans on the gp120 Envelope

Pradimicin S, a Highly Soluble Nonpeptidic Small-Size Carbohydrate-Binding Antibiotic, Is an Anti-HIV Drug Lead for both Microbicidal and Systemic Use

Predictive Value of HIV-1 Genotypic Resistance Test Interpretation Algorithms

The genealogical population dynamics of HIV-1 in a large transmission chain: bridging within and among host evolutionary rates

Human Immunodeficiency Virus Type 1 Escape from Cyclotriazadisulfonamide-Induced CD4-Targeted Entry Inhibition Is Associated with Increased Neutralizing Antibody Susceptibility

Novel Recombinant Virus Assay for Measuring Susceptibility of Human Immunodeficiency Virus Type 1 Group M Subtypes To Clinically Approved Drugs

Chronic and Early Antiretroviral Therapy Impact Human Immunodeficiency Virus (HIV) Serological Assay Sensitivity, Leading to More False-Negative Test Results in HIV Diagnosis

HIV-1 genetic variation and drug resistance development

Cellular HIV-1 DNA levels in drug sensitive strains are equivalent to those in drug resistant strains in newly-diagnosed patients in Europe

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database

Quality Control of Next-Generation Sequencing-Based HIV-1 Drug Resistance Data in Clinical Laboratory Information Systems Framework

Nationwide quality assurance of high-throughput diagnostic molecular testing during the SARS-CoV-2 pandemic: role of the Belgian National Reference Centre

The hepatitis C cascade of care in the Belgian HIV population: One step closer to elimination

Phylogenetic Analysis of Hepatitis C Virus Infections in a Large Belgian Cohort Using Next-Generation Sequencing of Full-Length Genomes

HIV genotypic drug resistance testing: digging deep, reaching wide?

Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections

Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic

Exploring HIV-1 Transmission Dynamics by Combining Phylogenetic Analysis and Infection Timing

Earlier Initiation of Antiretroviral Treatment Coincides With an Initial Control of the HIV-1 Sub-Subtype F1 Outbreak Among Men-Having-Sex-With-Men in Flanders, Belgium

Pradimicin A, a Carbohydrate-Binding Nonpeptidic Lead Compound for Treatment of Infections with Viruses with Highly Glycosylated Envelopes, Such as Human Immunodeficiency Virus

Comparative Performances of HIV-1 RNA Load Assays at Low Viral Load Levels: Results of an International Collaboration

Stable level of HIV transmitted drug resistance in Estonia despite significant scale-up of antiretroviral therapy

Decision tree for accurate infection timing in individuals newly diagnosed with HIV-1 infection

Mutational Pathways, Resistance Profile, and Side Effects of Cyanovirin Relative to Human Immunodeficiency Virus Type 1 Strains with N-Glycan Deletions in Their gp120 Envelopes

Quantifying Next Generation Sequencing Sample Pre-Processing Bias in HIV-1 Complete Genome Sequencing

Suchergebnisse filtern